Physician profile
Arshad Bachelani
NPI 1114177433
$11,434.38
in general payments reported to CMS, 2019-2025
11 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $26.55 · 2021: $91.71 · 2022: $5,909 · 2023: $4,546 · 2024: $591 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,243 · Travel and Lodging: $58.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,243.06 |
| Travel and Lodging | $58.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,987.86 | 2019-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Davol INC. | $565.69 | 2020-2023 | Arista Ah Flexitip |
| Conmed Corporation | $245.11 | 2022-2024 | Airseal |
| Integra Lifesciences Corporation | $164.22 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $157.52 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Astrazeneca Pharmaceuticals LP | $131.00 | 2024 | |
| Ethicon US, LLC | $94.93 | 2022-2024 | Ethicon, Enseal X1 |
| Innovation Technologies INC | $45.01 | 2022 | |
| Kci USA, INC. | $15.13 | 2020 | |
| Melinta Therapeutics, LLC | $14.91 | 2019 | |
| Merck Sharp & Dohme LLC | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshad Bachelani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.